Migraine in women: The role of hormones and their impact on vascular diseases

Journal of Headache and Pain

Volumn 13, Issue 3, 2012, Pages 177-189

  Sacco, Simona ^a   Ricci, Silvia ^a   Degan, Diana ^a   Carolei, Antonio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Contraceptive; Hormones; Menopause; Migraine; Pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; CONTRACEPTIVE AGENT; ESTRADIOL; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE;

BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; FEMALE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; LUTEINIZING HORMONE RELEASE; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE WITH AURA; MORTALITY; OVARY FOLLICLE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SEX DIFFERENCE; STROKE; VASCULAR DISEASE;

FEMALE; GONADAL STEROID HORMONES; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; RISK FACTORS; VASCULAR DISEASES;

EID: 84861481365     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-012-0424-y     Document Type: Review

References (140)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343-349 (Pubitemid 46184209)
2. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB (2008) Cumulative lifetime migraine incidence in women and men. Cephalalgia 28:1170-1178
3. Lipton RB, Bigal ME (2005) Migraine: epidemiology, impact, and risk factors for progression. Headache 45:S3-S13 (Pubitemid 40532985)
4. Russell MB, Rasmussen BK, Fenger K, Olesen J (1996) Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 16:239-245 (Pubitemid 26189249)
5. Takele GM, Tekle HR, Martelletti P (2008) Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia. J Headache Pain 9:119-128
6. TeVelde E, Pearson P (2002) The variability of female reproductive aging. Hum Reprod Update 8:141-154
7. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Nappi G (2000) Migraine with aura and reproductive life events: a case control study. Cephalalgia 20:701-707 (Pubitemid 32127837)
8. Wober C, Brannath W, Schmidt K, Kapitan M, Rudel E, Wessely P, Wober-Bingol C (2007) Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia 27:304-314 (Pubitemid 46434955)
9. Dzoljic E, Sipetic S, Vlajinac H, Marinkovic J, Brzakovic B, Pokrajac M, Kostic V (2002) Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 42:185-193 (Pubitemid 34260608)
10. Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M (1995) Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 45:1076-1082
11. MacGregor EA, Hackshaw A (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63:351-353 (Pubitemid 38971141)
12. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD (2000) Menstrual cycle and headache in a population sample of migraineurs. Neurology 55:1517-1523
13. International Headache Society (2004) The international classification of headache disorders, 2nd edition. Cephalalgia 24:1-160
14. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M (1995) Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 15:140-144
15. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC (1993) Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 33:385-389 (Pubitemid 23221829)
16. MacGregor EA, Chia H, Vohrah RC, Wilkinson M (1990) Migraine and menstruation: a pilot study. Cephalalgia 10:305-310
17. Vetvik KG, MacGregor EA, Lundqvist C, Russell MB (2010) Self-reported menstrual migraine in the general population. J Headache Pain 11:87-92
18. MacGregor EA (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3:354-361
19. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67:2154-2158 (Pubitemid 46035468)
20. Couturier EG, Bomhof MA, Neven AK, van Duijn NP (2003) Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 23:302-308 (Pubitemid 36577949)
21. Dowson AJ, Kilminster SG, Salt R, Clark M, Bundy MJ (2005) Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache 45:274-282 (Pubitemid 40530191)
22. Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, Brundu B, Facchinetti F, Nappi G (2004) Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 24:707-716 (Pubitemid 39209074)
23. MacGregor E, Victor T, Hu X, Xiang Q, Puenpatom R, Chen W, Campbell J (2010) Characteristics of menstrual vsnonmenstrual migraine: a post hoc, within woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache 50:528-538
24. Pinkerman B, Holroyd K (2010) Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia 30:1187-1194
25. Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P (2008) Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache 48:248-258 (Pubitemid 351178257)
26. Facchinetti F, Neri I, Martignoni E, Fioroni L, Nappi G, Genazzani AR (1993) The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 13:422-425 (Pubitemid 24017460)
27. Martin VT, Wernke S, Mandell K, Ramadan N, Kao L, Bean J, Liu J, Zoma W, Rebar R (2006) Symptoms of premenstrual syndrome and their association with migraine headache. Headache 46:125-137
28. Aegidius K, Zwart JA, Hagen K, Stovner L (2009) The effect of pregnancy and parity on headache prevalence: the Head-HUNT study. Headache 49:851-859
29. Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M (2011) Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 12:443-451
30. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, Nappi G (2003) Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 23:197-205 (Pubitemid 36461389)
31. Melhado E, Maciel JA Jr, Guerreiro CA (2005) Headaches during pregnancy in women with a prior history of menstrual headaches. Arq Neuropsiquiatr 63:934-940 (Pubitemid 43211525)
32. Marcus DA, Scharff L, Turk D (1999) Longitudinal prospective study of headache during pregnancy and postpartum. Headache 39:625-632
33. Estrevag JM, Zwart JA, Helde G, Johnsen HJ, Bovim G (2005) Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 111:233-237 (Pubitemid 40380458)
34. Somerville BW (1972) A study of migraine in pregnancy. Neurology 22:824-828
35. Maggioni F, Alessi C, Maggino T, Zanchin G (1997) Headache during pregnancy. Cephalalgia 17:765-769 (Pubitemid 27505102)
36. Bushnell CD, Jamison M, James AH (2009) Migraine during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ 338:b664
37. Facchinetti F, Allais G, Nappi RE, D'Amico R, Marozio L, Bertozzi L, Ornati A, Benedetto C (2009) Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 29:286-292
38. Blair EM, Nelson KB (2011) Migraine and preterm birth. J Perinatol 31:434-439
39. Chen HM, Chen SF, Chen YH, Lin HC (2010) Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia 30:433-438
40. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH (2003) Migraine prevalence during menopausal transition. Headache 43:470-478
41. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S (2008) Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol 111:127-136
42. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR (1993) Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 17:31-37
43. Mattsson P (2003) Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 43:27-35
44. Sabia S, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel- Chapelon F (2008)Risk factors for onset of menopausal symptoms: results from a large cohort study. Maturitas 60:108-121
45. Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ (2006) Oral contraceptives and increased headache prevalence: the Head-HUNT study. Neurology 66:349-353 (Pubitemid 43739935)
46. Mueller L (2000) Predictability of exogenous hormone effect in subgroups of migraineurs. Headache 40:189-193
47. Massiou H, MacGregor EA (2000) Evolution and treatment of migraine with oral contraceptives. Cephalalgia 20:170-174 (Pubitemid 32269505)
48. Loder EW, Buse DC, Golub JR (2005) Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 193:636-649 (Pubitemid 41261456)
49. MacGregor EA, Hackshaw A (2002) Prevention of migraine in the pill-free week of combined oral contraceptives using natural oestrogen supplements. J Fam Plann Reprod Health Care 28:27-31 (Pubitemid 34150522)
50. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95:261-266 (Pubitemid 30045651)
51. Sulak P, Willis S, Kuehl T, Coffee A, Clark J (2007) Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47:27-37 (Pubitemid 46096054)
52. Edelman A, Gallo MF, Nichols MD, Jensen JT, Schulz KF, Grimes DA (2006) Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. Hum Reprod 21:573-578 (Pubitemid 43372958)
53. LaGuardia KD, Fisher AC, Bainbridge JD, LoCoco JM, Friedman AJ (2005) Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 83:1875-1877 (Pubitemid 40824834)
54. De Leo V, Scolaro V, Musacchio MC, Di Sabatino A, Morgante G, Cianci A (2011) Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril 96:917-920
55. Curtis KM, Chrisman CE, Peterson HB (2002) Contraception for women in selected circumstances. Obstet Gynecol 99:1100-1102
56. Nappi RE, Sances G, Allais G, Terreno E, Benedetto C, Vaccaro V, Polatti F, Facchinetti F (2011) Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception 83:223-228
57. Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, Rexrode KM (2003) Post-menopausal hormone therapy and migraine headache. J Womens Health (Larchmt) 12:1027-1036 (Pubitemid 38072421)
58. Chinn MA (1968) Oestrogen therapy and migraine. Br Med J 2:699
59. Hodson J, Thompson J, al-Azzawi F (2000) Headache at menopause and in hormone replacement therapy users. Climacteric 3:119-124 (Pubitemid 30610055)
60. Moorhead T, Hannaford P, Warskyj M (1997) Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 104:290-297 (Pubitemid 27112659)
61. Warren MP, Kulak J Jr (1998) Is estrogen replacement indicated in perimenopausal women? Clin Obstet Gynecol 41:976-987 (Pubitemid 29320440)
62. MacGregor A (1999) Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia 19:124-125
63. Kaiser HJ, Meienberg O (1993) Deterioration of onset of migraine under oestrogen replacement therapy in the menopause. J Neurol Neurosurg Psychiatr 240:195-197
64. Martin VT (2004) Menstrual migraine: a review of prophylactic therapies. Curr Pain Headache Rep 8:229-237
65. Somerville BW (1972) The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22:355-365
66. Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I (2005) Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache 45:215-219 (Pubitemid 40393210)
67. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL (2002) Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 186:1142-1149 (Pubitemid 34665050)
68. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR (2004) The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/ control groups. Neurogenetics 5:129-133 (Pubitemid 38828673)
69. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR (2005) Investigation of hormone receptor genes in migraine. Neurogenetics 6:17-23 (Pubitemid 40394826)
70. Aloisi A (2003) Gonadal hormones and sex differences in pain reactivity. Clin J Pain 19:168-174
71. Stoffel-Wagner B (1993) Neurosteroid biosynthesis in the human brain and its clinical implications. Ann NY Acad Sci 1007:64-78
72. Facchinetti F, Martignoni E, Fioroni L, Sances G, Genazzani AR (1990) Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. Cephalalgia 10:51-56 (Pubitemid 20183808)
73. Horrobin D (1977) Prostaglandins and migraine. Headache 16:113-116
74. Carlson LA, Ekelund LG, Orö L (1968) Clinical and metabolic effects of different doses of prostaglandin E1 in man. Prostaglandin and related factors. Acta Med Scand 183:423-430
75. Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part I. Headache 46:3-23
76. Akcali D, Sayin A, Sara Y, Bolay H (2010) Does single cortical spreading depression elicit pain behaviour in freely moving rats? Cephalalgia 30:1195-1206
77. Marrannes R, Willems R, De Prins E, Wauquier A (1988) Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res 457:226-240
78. Muneyvirci-Delale O, Nacharaju VL, Altura BM, Altura BT (1998) Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women. Fertil Steril 69:958-962 (Pubitemid 28193935)
79. Fioroni L, Martignoni E, Facchinetti F (1995) Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia 15:297-300
80. Facchinetti F, Sgarbi L, Piccinini F (2000) Hypothalamic resetting at puberty and the sexual dimorphism of migraine. Funct Neurol 15:137-142 (Pubitemid 32051386)
81. Brandes JL (2006) The influence of estrogen on migraine: a systematic review. JAMA 295:1824-1830
82. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW (1999) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406 (Pubitemid 29069990)
83. Sarchielli P, Tognoloni M, Russo S, Vulcano MR, Feleppa M, Malà M, Sartori M, Gallai V (1996) Variations in the platelet arginine/ nitric oxide pathway during the ovarian cycle in females affected by menstrual migraine. Cephalalgia 16:468-475 (Pubitemid 26373783)
84. Edwards HE, Burnham WM, Mendonca A, Bowlby DA, MacLusky NJ (1999) Steroid hormones affect limbic after discharge thresholds and kindling rates in adult female rats. Brain Res 838:136-150 (Pubitemid 29389828)
85. Hattemer K, Knake S, Reis J, Oertel WH, Rosenow F, Hamer HM (2006) Cyclical excitability of the motor cortex in patients with catamenial epilepsy: a transcranial magnetic stimulation study. Seizure 15:653-657 (Pubitemid 44645424)
86. Bousser MG, Welch KM (2005) Relation between migraine and stroke. Lancet Neurol 4:533-542
87. Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on stroke in the young. Lancet 347:1503-1506
88. Sacco S, Olivieri L, Bastianello S, Carolei A (2006) Comorbid neuropathologies in migraine. J Headache Pain 7:222-230 (Pubitemid 46206337)
89. Sacco S, Cerone D, Carolei A (2008) Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain 9:237-248
90. Sacco S, Ricci S, Carolei A (2012) Vascular vulnerability in migraineurs (in press)
91. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914
92. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283-291 (Pubitemid 44079312)
93. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE (2007) Migraine and risk of cardiovascular disease in men. Arch Intern Med 167:795-801 (Pubitemid 46658337)
94. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease: a population-based study. Neurology 74:628-635
95. Gudmundsson LS, Scher AI, Aspelund T, Eliasson JH, Johannsson M, Thorgeirsson G, Launer L, Gudnason V (2010) Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 341:c3966
96. Schürks M, Rist PM, Shapiro RE, Kurth T (2011) Migraine and mortality: a systematic review and meta-analysis. Cephalalgia 31:1301-1314
97. Bushnell CD (2005) Oestrogen and stroke in women: assessment of risk. Lancet Neurol 4:743-751
98. Miller VM, Duckles SP (2008) Vascular actions of estrogens: functional implications. Pharmacol Rev 60:210-241 (Pubitemid 351962010)
99. Skafar DF, Xu R, Morales J, Ram J, Sowers JR (1997) Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab 82:3913-3918 (Pubitemid 27525485)
100. Farhat MY (1996) The vascular protective effects of estrogen. FASEB J 10:615-624
101. Moragham T, Antoniucci DM, Grenert JP, Sieck GC, Johnson C, Miller VM, Fitzpatrick LA (1996) Differential response in cell proliferation to beta estradiol in coronary arterial vascular smooth muscle cells obtained form mature female vs. male animals. Endocrinology 137:5174-5177 (Pubitemid 26403366)
102. Oparil S, Levin RL, Chen YF (1996) Sex hormones and the vasculature. In: Sowers JR (ed) Endocrinology of the vasculature. Humana Press, Totowa, pp 225-238
103. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW (1993) Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 109:612-617 (Pubitemid 23181035)
104. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G (1992) Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 89:11259-11263
105. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S (1994) Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA 91:5212-5216 (Pubitemid 24177823)
106. Hayashi T (1995) Estrogen increased endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214:847-855
107. Hishikawa K (1995) Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360:291-293
108. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM (1994) Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89:1501-1510 (Pubitemid 24114224)
109. Lin AL, Gonzalez R, Carey KD, Shain SA (1986) Estradiol-17 affects E2 receptor distribution and elevates P receptor content in baboon aorta. Arteriosclerosis 6:495-504 (Pubitemid 16004366)
110. Miller VM, Vanhoutte PM (1991) Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 261:R1022-R1027
111. Hanke H, Hanke S, Bruck B, Brehme U, Gugel N, Finking G, Mück AO, Schmahl FW, Hombach V, Haasis R (1996) Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis 121:129-138 (Pubitemid 26074215)
112. Hanke H, Hanke S, Finking G, Muhic-Lohrer A, Mück AO, Schmahl FW, Haasis R, Hombach V (1996) Different effects of estrogen and progesterone on experimental atherosclerosis in female vs. male rabbits. Quantification of cellular proliferation by bromodeoxyuridine. Circulation 94:175-181 (Pubitemid 26240554)
113. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH (1996) Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progestins, in the human endometrium. J Clin Invest 97:403-412 (Pubitemid 26039404)
114. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P (1992) Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 211:163-167
115. Raman BB, Standley PR, Rajkumar V, Ram JL, Sowers JR (1995) Effects of estradiol and progesterone on platelet calcium responses. Am J Hypertens 8:197-200
116. Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 323:131-134 (Pubitemid 32678382)
117. Baillargeon JP, McClish DK, Essah PA, Nestler JE (2005) Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 90:3863-3870 (Pubitemid 41058144)
118. Petitti DB (2003) Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med 349:1443-1450
119. Chang CL, Donaghy M, Poulter N (1999) Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of cardiovascular disease and steroid hormone contraception. BMJ 318:13-18
120. Collaborative Group for the Study of Stroke in Young Women (1975) Oral contraceptives and stroke in young women. JAMA 231:718-722
121. Lidegaard Ø (1993) Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ 306:956-963
122. Lidegaard Ø (1995) Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynaecol 102:153-159
123. MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, Kittner SJ (2007) Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 38:2438-2445 (Pubitemid 47329619)
124. Schwartz SM, Petitti DB, Siscovick DS, Longstreth WT Jr, Sidney S, Raghunathan TE, Quesenberry CP Jr, Kelaghan J (1998) Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke 29:2277-2284 (Pubitemid 28511944)
125. Tzourio C, Tehindrazanarivelo A, Iglésias S, Alpérovitch A, Chedru F, d'Anglejan-Chatillon J, Bousser MG (1995) Case- control study of migraine and risk of ischaemic stroke in young women. BMJ 310:830-833
126. Curtis KM, Mohllajee AP, Peterson HB (2006) Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 73:189-194 (Pubitemid 43087768)
127. Hersh AL, Stefanick ML, Stafford RS (2004) National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291:47-53 (Pubitemid 38040534)
128. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613 (Pubitemid 28502636)
129. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345:1243-1249 (Pubitemid 34951488)
130. Evenson KR, Wilcox S, Pettinger M, Brunner R, King AC, McTiernan A, Women's Health Initiative Observational Cohort Study (2002) Vigorous leisure activity through women's adult life: the women's health initiative observational cohort study. Am J Epidemiol 156:945-953 (Pubitemid 35304075)
131. Hemelaar M, van der Mooren M, Rad M, Kluft C, Kenemans P (2008) Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertil Steril 90:642-672
132. Arana A, Varas C, Gonzalez-Perez A, Gutierrez L, Bjerrum L, Garcia Rodriguez LA (2006) Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause 13:730-736 (Pubitemid 44435027)
133. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ (2000) A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133:922-941
134. Renoux C, Dell'Aniello S, Garbe E, Suissa S (2010) Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 340:c2519
135. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J (2006) Effects of conjugated equine estrogen on stroke in the women's health initiative. Circulation 113:2425-2434 (Pubitemid 43948050)
136. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ (2003) Effect of estrogen plus progestin on stroke in postmenopausal women. The women's health initiative: a randomized trial. JAMA 289:2673-2684 (Pubitemid 37430138)
137. ACOG Committee on Practice Bulletins-Gynecology (2006) ACOG practice bulletin. No 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107:1453-1472
138. Bousser MG, Conard J, Kittner S, de Lignières B, MacGregor EA, Massiou H, Silberstein SD, Tzourio C (2000) Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on combined oral contraceptives & hormone replacement therapy. Cephalalgia 20:155-156 (Pubitemid 32269502)
139. Faculty of Sexual and Reproductive Health Care (2009) UK medical eligibility criteria for contraceptive use (UKMEC 2009). Royal College of Obstetricians and Gynaecologists
140. World Health Organization (2004) Medical eligibility criteria for contraceptive use, 3rd edn. World Health Organization, Geneva